1. Home
  2. DNTH vs ENIC Comparison

DNTH vs ENIC Comparison

Compare DNTH & ENIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

N/A

Current Price

$84.41

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Logo Enel Chile S.A. (Each representing 50 shares of)

ENIC

Enel Chile S.A. (Each representing 50 shares of)

N/A

Current Price

$4.01

Market Cap

6.3B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
DNTH
ENIC
Founded
2015
2016
Country
United States
Chile
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
6.3B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
DNTH
ENIC
Price
$84.41
$4.01
Analyst Decision
Strong Buy
Hold
Analyst Count
18
5
Target Price
★ $139.25
$4.94
AVG Volume (30 Days)
★ 723.8K
566.7K
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
★ 4.85%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,036,000.00
N/A
Revenue This Year
$22.80
$12.31
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$101.18
Revenue Growth
N/A
★ N/A
52 Week Low
$35.84
$3.68
52 Week High
$117.88
$4.74

Technical Indicators

Market Signals
Indicator
DNTH
ENIC
Relative Strength Index (RSI) 44.01 34.40
Support Level $79.54 $3.86
Resistance Level $91.36 $4.65
Average True Range (ATR) 4.84 0.09
MACD -0.08 -0.03
Stochastic Oscillator 19.24 9.26

Price Performance

Historical Comparison
DNTH
ENIC

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

About ENIC Enel Chile S.A. (Each representing 50 shares of)

Enel Chile SA is an electricity utility company engaged, through its subsidiaries and affiliates, in the generation, transmission, and distribution of electricity across Chile. The Company operates through two main segments: the Generation Business, which includes companies that own and operate power plants supplying electricity to the grid and generates the majority of revenue; and the Distribution and Network Business, which consists of companies operating under public utility concessions to distribute electricity to end customers.

Share on Social Networks: